Fengwei Li

945 total citations · 1 hit paper
24 papers, 514 citations indexed

About

Fengwei Li is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Fengwei Li has authored 24 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Fengwei Li's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), MicroRNA in disease regulation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Fengwei Li is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), MicroRNA in disease regulation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Fengwei Li collaborates with scholars based in China, Hong Kong and United States. Fengwei Li's co-authors include Qinjunjie Chen, Kui Wang, Leilei Liang, Feng Shen, Yong Xia, Yiran Zou, Zheng Li, Zhangjun Cheng, Jun Li and Hao Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cell Metabolism.

In The Last Decade

Fengwei Li

22 papers receiving 497 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription

2021 171 citations Qinjunjie Chen, Haibo Wang et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengwei Li China	13	280	211	71	69	55	24	514
Lingxiang Yu China	16	397 1.4×	284 1.3×	84 1.2×	63 0.9×	50 0.9×	48	703
Dan Kong China	14	306 1.1×	181 0.9×	42 0.6×	42 0.6×	42 0.8×	34	538
Qiao Wang China	13	298 1.1×	269 1.3×	51 0.7×	45 0.7×	36 0.7×	26	549
Meng Guo China	16	315 1.1×	156 0.7×	47 0.7×	59 0.9×	137 2.5×	32	704
Shuoyi Ma China	10	204 0.7×	144 0.7×	123 1.7×	48 0.7×	48 0.9×	25	394
Xiangyu Dai China	13	562 2.0×	440 2.1×	121 1.7×	32 0.5×	78 1.4×	19	804
Dan Huang China	14	245 0.9×	149 0.7×	74 1.0×	33 0.5×	62 1.1×	51	652
Heping Yang China	10	236 0.8×	114 0.5×	38 0.5×	95 1.4×	62 1.1×	24	499
Haoyun Zhang China	11	204 0.7×	110 0.5×	104 1.5×	40 0.6×	139 2.5×	28	519
Jiansi Chen China	16	216 0.8×	162 0.8×	134 1.9×	141 2.0×	20 0.4×	33	515

Countries citing papers authored by Fengwei Li

Since Specialization

Citations

This map shows the geographic impact of Fengwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengwei Li more than expected).

Fields of papers citing papers by Fengwei Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengwei Li. The network helps show where Fengwei Li may publish in the future.

Co-authorship network of co-authors of Fengwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fengwei Li. A scholar is included among the top collaborators of Fengwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengwei Li. Fengwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Yuanxun, et al.. (2025). Research on construction risk assessment method of shield tunnel based on subjective and objective weights. Journal of Engineering and Applied Science. 72(1).

Zong, Chen, Hui Xue, Yao Li, et al.. (2024). YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis. The Journal of Gene Medicine. 26(5). e3689–e3689. 4 indexed citations

Li, Yao, et al.. (2024). Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma. Theranostics. 14(9). 3526–3547. 12 indexed citations

Li, Fengwei, et al.. (2024). Investigation of collector desorption behavior on the coal surface during flotation conditioning. Asia-Pacific Journal of Chemical Engineering. 19(4).

Liu, Jianwei, Yong Xia, Caixia Lü, et al.. (2023). The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion. The Oncologist. 28(11). e1043–e1051. 12 indexed citations

Li, Fengwei, Jianing Zhang, Jinchi Zhang, et al.. (2023). Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma. Genomics. 115(3). 110621–110621. 4 indexed citations

Hou, Xiaojuan, Luyao Zhang, Changchun Shao, et al.. (2022). 3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages. Frontiers in Oncology. 12. 877982–877982. 5 indexed citations

Wang, Jiang, Jing Zhao, Cong Yan, et al.. (2022). Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial. Cell Metabolism. 34(5). 667–680.e6. 31 indexed citations

Chen, Qinjunjie, Haibo Wang, Zheng Li, et al.. (2021). Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. Journal of Hepatology. 76(1). 135–147. 171 indexed citations breakdown →

10.

Li, Fengwei, Qinjunjie Chen, Yang Yang, et al.. (2021). ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis. Cancer Cell International. 21(1). 225–225. 3 indexed citations

11.

Huang, Yihua, Xue Yang, Yan Meng, et al.. (2021). The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages. Cell & Bioscience. 11(1). 173–173. 39 indexed citations

12.

Li, Fengwei, et al.. (2021). Naringin attenuates rat myocardial ischemia/reperfusion injury via PI3K/Akt pathway‑mediated inhibition of apoptosis, oxidative stress and autophagy. Experimental and Therapeutic Medicine. 22(2). 811–811. 24 indexed citations

13.

Yue, Chao, et al.. (2020). Association between air pollutants and atrial fibrillation in general population: A systematic review and meta-analysis. Ecotoxicology and Environmental Safety. 208. 111508–111508. 37 indexed citations

14.

Li, Fengwei, et al.. (2020). SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway. Molecular Therapy — Nucleic Acids. 23. 1066–1077. 25 indexed citations

15.

Chen, Qinjunjie, Fengwei Li, Cheng‐Qian Zhong, et al.. (2020). Inflammation Score System using Preoperative Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma after Hepatectomy: A Cohort Study. Journal of Cancer. 11(17). 4947–4956. 12 indexed citations

16.

Li, Fengwei, Qinjunjie Chen, Hui Xue, et al.. (2020). LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis. Cell Death and Disease. 11(10). 894–894. 30 indexed citations

17.

Chen, Qinjunjie, Fengwei Li, Yuzhen Gao, et al.. (2020). Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 1210–1210. 57 indexed citations

18.

Yue, Chao, et al.. (2020). Association between fine particulate matter and atrial fibrillation in implantable cardioverter defibrillator patients: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 59(3). 595–601. 10 indexed citations

19.

Chu, Hongling, Lin Zeng, Nan Li, et al.. (2017). How novice, skilled and advanced clinical researchers include variables in a case report form for clinical research: a qualitative study. BMJ Open. 7(9). e016760–e016760. 3 indexed citations

20.

Jiang, Guanchao, Fengwei Li, Xiao Li, et al.. (2014). The study of the correlation between prognosis and the sequence of vessel interruption during thoracoscopic lobectomy for early stage non-small cell lung cancer. 30(9). 513–516. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact